(1)
Oddershede, J. K.; Meklenborg, I. K.; Bastholt, L.; Guldbrandt, L. M.; Schmidt, H.; Friis, R. B. Cardiotoxicity in Patients With Metastatic Melanoma Treated With BRAF MEK Inhibitors: A Real-World Analysis of Incidence, Risk Factors, and Reversibility. AO 2025, 64, 507-515.